====== University of Alberta ======

{{ ::372-3727849_university-of-alberta-logo-lives-of-the-ancient.png?200|}}

**University of Alberta** is a Canadian university in [[canada:alberta:Edmonton]], [[canada:Alberta]].

===== History =====

==== COVID-19 ====

U of A received a $46,585 CAD grant in July 2021 from the [[Government of Canada]] for a project titled "WISEST: Building Confidence in Vaccines in Girls and Young Women in Canada."((//Encouraging vaccine confidence in Canada - Competition Results.// (2021, July 26). Natural Sciences and Engineering Research Council of Canada (NSERC). Retrieved November 3, 2021, from https://archive.ph/Zo5b5)) It was awarded through a grant program called //"Encouraging Vaccine Confidence in Canada"// jointly administered by the [[Canadian Institutes of Health Research]] (CIHR), [[Natural Sciences and Engineering Research Council]] (NSERC) and the [[Social Sciences and Humanities Research Council]] (SSHRC).((//Encouraging vaccine confidence in Canada.// (2021, July 26). Natural Sciences and Engineering Research Council of Canada. Retrieved November 3, 2021, from https://www.nserc-crsng.gc.ca/Promoter-Promotion/VaccineConfidence_eng.asp))

In March 2022, the University announced the creation of the Pfizer Applied Clinical Pharmacology Program under the Faculty of Pharmacy and Pharmaceutical Sciences. The new program is in partnership with [[pharmaceutical_companies:Pfizer]] and [[Applied Pharmaceutical Innovation]] (API).((//Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program.// (2022, March 16). Applied Pharmaceutical Innovation. https://web.archive.org/web/20221026202112/https://appliedpharma.ca/pfizer-applied-pharmaceutical-innovation-and-university-of-alberta-launch-the-pfizer-applied-clinical-pharmacology-program/))

===== Organization =====

==== Metabolic and Cardiovascular Diseases Laboratory ====

U of A's MCDL has previously received research funding from:((//Previous Funding Partners.// Metabolic and Cardiovascular Diseases Laboratory. Retrieved October 26, 2022, from https://web.archive.org/web/20221026204817/https://mcvd.ualberta.ca/research/previous-funding-partners/))

<WRAP column col4>
  * [[Advanced Foods and Materials Network]] (AFMNet)
  * [[Alberta Advanced Education and Technology]]
  * [[Alberta Diabetes Institute]] (ADI)
  * [[Alberta Health Services]] (AHS)
  * [[Alberta Innovates]]
  * [[Alberta Livestock and Meat Agency]] (ALMA)
  * [[American Society of Parenteral & Enteral Nutrition]]
  * [[Beef Information Centre]] (BIC)
  * [[Canada Foundation for Innovation]] (CFI)
  * [[Canadian Institutes of Health Research]] (CIHR)
  * [[Canadian Lipoprotein Conference]]
  * [[Ceapro]]
  * [[Dairy Farmers of Canada]]
  * [[Heart and Stroke Foundation of Canada]]
  * [[International Atherosclerosis Society]]
  * [[International Life Sciences Institute]]
  * [[pharmaceutical_companies:Johnson & Johnson]]
  * [[Mazankowski Alberta Hearth Institute]]
  * [[pharmaceutical_companies:Merck]]
  * [[MITACS]]
  * [[National Research Council Canada]] (NRC)
  * [[Natural Sciences and Engineering Research Council]] (NSERC)
  * [[Networks of Centres of Excellence of Canada]]
  * [[pharmaceutical_companies:Pfizer]]
  * [[pharmaceutical_companies:Sanofi-Aventis]]
  * [[Spanish Ministry of Science and Innovation]]
  * [[Stollery Children's Hospital Foundation]]
  * [[TEC Edmonton]]
  * [[University Hospital Foundation]]
  * [[Women's & Children's Health Research Institute]]
</WRAP>